Boc-L-Phe(4-NH2)-OH

Boc-L-Phe(4-NH2)-OH is a Boc-protected L-phenylalanine derivative bearing a para-amino substituent on the aromatic ring, providing an aniline-functionalized side chain while keeping the α-amino group masked for peptide chemistry. This protected amino acid building block is commonly used to introduce a phenylalanine residue with a reactive primary amine handle into peptides and peptide-based intermediates, enabling downstream derivatization without interfering with standard coupling conditions for the backbone.

1. Peptide Library Construction

Boc-L-Phe(4-NH2)-OH is used by peptide synthesis groups to incorporate a phenylalanine side chain that carries a para-primary amine, supporting the rapid generation of peptide libraries where side-chain functionalization is performed after assembly. The Boc protection on the α-amino group allows reliable coupling during protected-amino-acid workflows, while the ring amine provides a direct handle for introducing diversity through amide formation, sulfonamide formation, or further orthogonal protection strategies during lead optimization. Researchers in academic peptide chemistry and industrial peptide manufacturing commonly select this building block when they need a lysine-like functional group pattern but with an aromatic side chain that can influence conformation and binding-site interactions.

2. Medicinal Chemistry Intermediates

Boc-L-Phe(4-NH2)-OH is widely employed in medicinal chemistry for preparing peptide-conjugation intermediates and amino acid-derived fragments that require a para-amino functionality for late-stage coupling. The retained primary amine enables straightforward attachment to carboxylic acids, activated sulfonyl groups, or electrophiles used to build SAR-focused series, while the Boc-protected backbone minimizes uncontrolled side reactions during fragment assembly. Pharmaceutical intermediate developers and custom synthesis teams use this reagent to access an aniline-bearing phenylalanine motif that can be carried through to final coupling steps in peptide-drug conjugate research or in the preparation of bioactive peptidomimetic scaffolds.

3. Bioconjugate Handle Installation

Boc-L-Phe(4-NH2)-OH serves as a practical amino acid platform for installing a primary amine handle into peptide scaffolds intended for bioconjugation workflows. After peptide assembly, the para-amino group can be used to generate conjugation-ready derivatives such as amide-linked tags, affinity handles, or linker-bearing intermediates that are compatible with common bioconjugation strategies. Chemical biology laboratories and biomaterials researchers often choose this building block when they want an aromatic side chain that positions the amine for controlled derivatization, while the Boc protection ensures the backbone remains protected during synthesis and downstream purification of the assembled peptide intermediate.

4. Functionalized Peptide Derivatization

Boc-L-Phe(4-NH2)-OH is used to prepare peptides that will undergo post-synthetic side-chain modification, including attachment of solubilizing groups, labels, or steric/charge-modifying substituents derived from the aniline functionality. The presence of a primary amine on the para position provides a chemically accessible site for controlled derivatization, allowing researchers to tune properties such as polarity and local interaction patterns without redesigning the peptide backbone. Peptide development teams in chemical biology and materials-focused protein/peptide engineering projects rely on this reagent when they need a stable, protected amino acid building block that delivers a specific functional group placement for subsequent modification steps.

1. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

2. TMEM16F and dynamins control expansive plasma membrane reservoirs

3. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

4. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

5. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines